Mawer Investment Management Ltd. reduced its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 32.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 215,153 shares of the conglomerate’s stock after selling 104,430 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Danaher were worth $47,667,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Main Street Group LTD acquired a new stake in shares of Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new stake in Danaher during the second quarter worth $25,000. Marquette Asset Management LLC grew its holdings in Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 73 shares during the last quarter. Field & Main Bank acquired a new stake in Danaher in the second quarter valued at $29,000. Finally, Solstein Capital LLC acquired a new stake in Danaher in the second quarter valued at $33,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other Danaher news, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at $5,158,277.54. This trade represents a 8.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 10.80% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently issued reports on DHR. DZ Bank downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Robert W. Baird raised their target price on shares of Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a report on Thursday, October 22nd. TD Cowen lifted their target price on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. Citigroup upped their price target on shares of Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $275.00 price target on shares of Danaher in a research report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $242.91.
Check Out Our Latest Stock Report on DHR
Danaher Price Performance
Shares of NYSE DHR traded up $1.00 during trading on Friday, reaching $233.16. The company had a trading volume of 3,359,470 shares, compared to its average volume of 4,152,061. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market capitalization of $164.04 billion, a PE ratio of 38.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.76. The stock has a 50-day moving average price of $222.56 and a two-hundred day moving average price of $201.52. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The business’s revenue was up 8.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.89 earnings per share. As a group, sell-side analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s payout ratio is presently 26.19%.
Danaher Profile
Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.
Featured Articles
- Five stocks we like better than Danaher
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
